'Finlay Vaccine Institute') is a Cuban organization that carries out medical research and mainly produces vaccines.

It is named after the Cuban doctor Carlos Finlay, who was the first to hypothesize the involvement of a mosquito as a vector of yellow fever.

[2] In response to fight against COVID-19, Finlay Institute has developed the Soberana 02.

[3] In March 2021, Vicente Vérez, director of the Finlay Institute, announced a delay in the development of vaccines and indicated the start of vaccination of the Cuban population in July 2021.

You can help Wikipedia by expanding it.This Cuba-related article is a stub.